Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Geneticists Identify Chronic Pain Gene

By LabMedica International staff writers
Posted on 16 Aug 2010
Researchers have identified a gene linked to susceptibility and response to chronic pain caused by nerve injury.

Investigators at the Hebrew University of Jerusalem (Israel) used advanced genomic techniques to pinpoint a 155 gene segment of chromosome 15 as the source of the gene responsible for encoding the pain-related protein stargazin. More...
They then used bioinformatics and whole-genome microarray expression analysis to narrow the list of candidates and ultimately to pinpoint the gene Cacng2 as the likely candidate. These findings were published in the August 5, 2010, issue of the journal Genome Research.

Confirmation of the role of Cacng2 was obtained by studying the behavior of "stargazer mice,” a Cacng2 hypomorphic mutant. These mice provided electrophysiological and behavioral evidence for the gene's functional role in pain processing. Finally, the investigators showed that human CACNG2 polymorphisms were associated with chronic pain in a cohort of cancer patients who underwent breast surgery.

"The immediate significance is the mere awareness that differences in pain perception may have a genetic predisposition,” said senior author Dr. Ariel Darvasi, professor of genetics at the Hebrew University of Jerusalem. "Our discovery may provide insights for treating chronic pain through previously unthought-of mechanisms.”

Related Links:

Hebrew University of Jerusalem




Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.